Source:http://linkedlifedata.com/resource/pubmed/id/18344414
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2008-5-2
|
pubmed:abstractText |
Diminished lung function, indicated by a low forced expiratory volume in one second (FEV1), and short physical stature, predict early mortality from all causes, including cardiovascular, among smokers and never smokers. The basis for these associations is unclear, and, it is not known if there is a pulmonary morphological component to the relationship between low FEV1 and early death in a general population. Some apolipoprotein E genotypes also predict atherosclerosis and early mortality. These considerations led us to examine the Apoe(tm1Unc) (Apoe) mouse, in which the apolipoprotein E gene is deleted, and that develops dyslipidemia, atherosclerosis at an early age, and has a shorter life span than the founder wild-type (wt) strain. We asked if Apoe mice have a morphological or functional pulmonary phenotype. We measured the size, number, and surface area of pulmonary gas-exchange units (alveoli) and mechanical properties of the lung. Compared with wt mice, Apoe mice had: 1) diminished developmental alveologenesis, 2) increased airway resistance in early adulthood, 3) high lung volume and high dynamic and static compliance in later adulthood, 4) more rapid loss of lung recoil with age, and 5) were less long than wt mice. These findings in mice indicate the association of a low FEV1 with early death in humans may have developmental, and accelerated ageing, related pulmonary components, and that dietary, genetic, or dietary and genetic influences, on lipid metabolism may be an upstream cause of inflammation and oxidative stress, currently considered to be major risk factors for COPD.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1040-0605
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
294
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
L991-7
|
pubmed:meshHeading |
pubmed-meshheading:18344414-Aging,
pubmed-meshheading:18344414-Animals,
pubmed-meshheading:18344414-Apolipoproteins E,
pubmed-meshheading:18344414-Atherosclerosis,
pubmed-meshheading:18344414-Body Size,
pubmed-meshheading:18344414-Body Weight,
pubmed-meshheading:18344414-Disease Models, Animal,
pubmed-meshheading:18344414-Lung,
pubmed-meshheading:18344414-Lung Volume Measurements,
pubmed-meshheading:18344414-Male,
pubmed-meshheading:18344414-Mice,
pubmed-meshheading:18344414-Mice, Inbred C57BL,
pubmed-meshheading:18344414-Pulmonary Alveoli,
pubmed-meshheading:18344414-Respiratory Function Tests
|
pubmed:year |
2008
|
pubmed:articleTitle |
Apoetm1Unc mice have impaired alveologenesis, low lung function, and rapid loss of lung function.
|
pubmed:affiliation |
Department of Medicine, Lung Regeneration Laboratory, Georgetown Univ. School of Medicine, 3900 Reservoir Rd. NW, Washington, DC 20057-1481, USA. massarod@georgetown.edu
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|